Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA).

Saved in:
Bibliographic Details
Title: Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA).
Authors: Schoettler ML; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, USA., Pusarla SK; Omeros Corporation, Seattle, Washington, USA., Nangia N; Omeros Corporation, Seattle, Washington, USA., Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Duarte RF; Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Grauer A; Omeros Corporation, Seattle, Washington, USA., Rambaldi A; Department of Oncology and Hematology, University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII,Piazza OMS, Bergamo, Italy.
Source: American journal of hematology [Am J Hematol] 2025 Nov; Vol. 100 (11), pp. 2040-2051. Date of Electronic Publication: 2025 Aug 29.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-8652
DOI:10.1002/ajh.70044